Top Markets
Coin of the day
Allergy Therapeutics plc Allergy Therapeutics plc

Allergy Therapeutics plc

AGY
शेयरों में रैंक #35053
Allergy Therapeutics plc is a biotechnology firm dedicated to the research and... Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. Furthermore, Allergy Therapeutics is actively advancing new vaccine candidates designed to address sensitivities to trees, grass, house dust mites, animal dander, and peanuts. With operations spanning Central Europe, Southern Europe, the United Kingdom, and various other international markets, Allergy Therapeutics plc was established in 2004 and is headquartered in Worthing, UK.
शेयर मूल्य
$0.07143683
अंतिम समन्वयन: 2026-08-14
मार्केट कैप
$4.52M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
-37.27%
देश
GB
व्यापार Allergy Therapeutics plc (AGY)

श्रेणी

Allergy Therapeutics plc (AGY) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.07 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $58.26 (2004-10-01 को)
Allergy Therapeutics plc के स्टॉक मूल्य का इतिहास 2004 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -16.04%
2025 88.19%
2024 176.72%
2023 -99.80%
2022 -69.31%
2021 120.55%
2020 48.04%
2019 -21.26%
2018 -53.43%
2017 48.29%
2016 -45.73%
2015 27.66%
2014 178.24%
2013 -32.85%
2012 20.49%
2011 27.73%
2010 7,938.67%
2009 -81.34%
2008 147.20%
2007 -59.75%
2006 -83.07%
2005 -92.47%
2004 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$171.67 -
DE
$161.67 23.26%
DE
$36.61 22.16%
JP
$225.00 37.51%
CH
$21.30 13.79%
IN